ARK Investment Management LLC 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-10 3:12 pm Sale | 2021-02-28 | 13G | Syros Pharmaceuticals, Inc. SYRS | ARK Investment Management LLC | 858,960 13.940% | -45,172 (-5.00%) | Filing |
| 2021-02-16 4:33 pm Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | ARK Investment Management LLC | 904,132 19.740% | -217,119 (-19.36%) | Filing |
| 2020-10-09 2:16 pm Purchase | 2020-06-30 | 13G | Syros Pharmaceuticals, Inc. SYRS | ARK Investment Management LLC | 1,121,251 24.500% | 613,470 (+120.81%) | Filing |